These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 1799390)

  • 1. Interference of C17-spirosteroids with late steps of aldosterone biosynthesis. Structure-activity studies.
    Weindel K; Lewicka S; Vecsei P
    Arzneimittelforschung; 1991 Oct; 41(10):1082-91. PubMed ID: 1799390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of the novel anti-aldosterone compound mespirenone on adrenocortical steroidogenesis in vitro.
    Weindel K; Lewicka S; Vecsei P
    Arzneimittelforschung; 1991 Sep; 41(9):946-9. PubMed ID: 1796922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The renal action of spirorenone and other 6 beta,7 beta; 15 beta,16 beta-dimethylene-17-spirolactones, a new type of steroidal aldosterone antagonists.
    Casals-Stenzel J; Buse M; Wambach G; Losert W
    Arzneimittelforschung; 1984; 34(3):241-6. PubMed ID: 6329237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of type 2 17beta-hydroxysteroid dehydrogenase by estradiol derivatives bearing a lactone on the D-ring: structure-activity relationships.
    Bydal P; Auger S; Poirier D
    Steroids; 2004 May; 69(5):325-42. PubMed ID: 15219411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental studies on the endocrine side effects of new aldosterone antagonists.
    Nishino Y; Schröder H; el Etreby MF
    Arzneimittelforschung; 1988 Dec; 38(12):1800-5. PubMed ID: 3245852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mespirenone and other 15,16-methylene-17-spirolactones, a new type of steroidal aldosterone antagonists.
    Losert W; Bittler D; Buse M; Casals-Stenzel J; Haberey M; Laurent H; Nickisch K; Schillinger E; Wiechert R
    Arzneimittelforschung; 1986 Nov; 36(11):1583-600. PubMed ID: 3028435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of phospholipid on aldosterone biosynthesis by a cytochrome P-450(11) beta-reconstituted system.
    Ohnishi T; Wada A; Nonaka Y; Okamoto M; Yamano T
    Biochem Int; 1984 Dec; 9(6):715-23. PubMed ID: 6525204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in aldosterone synthase gene of Milan hypertensive rats: phenotypic consequences.
    Lloyd-MacGilp SA; Torielli L; Bechtel S; Tripodi G; Gomez-Sanchez CE; Zagato L; Bernhardt R; Kenyon CJ
    Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E608-17. PubMed ID: 11832364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extinction of mineralocorticoid effects in 19-norprogesterone derivatives: structure-activity relationships.
    Paris J; Botella J; Fournau P; Bonnet P; Thevenot R
    J Pharmacol Exp Ther; 1987 Oct; 243(1):288-91. PubMed ID: 2822901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [DARC/PELCO structure activity relationships of aldosterone agonists and antagonists].
    Mercier C; Auzou G; Tokay N
    J Pharm Belg; 1995; 50(2-3):223-30. PubMed ID: 7674121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progestogens with antimineralocorticoid activity.
    Losert W; Casals-Stenzel J; Buse M
    Arzneimittelforschung; 1985; 35(2):459-71. PubMed ID: 4039568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinolone antimicrobial agents: structure-activity relationships.
    Zhang MQ; Haemers A
    Pharmazie; 1991 Oct; 46(10):687-700. PubMed ID: 1803382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonists of oxytocin featuring replacement with modified beta-mercaptopropionic acids at position 1.
    Flouret G; Majewski T; Balaspiri L; Brieher W; Mahan K; Chaloin O; Wilson L; Slaninová J
    J Pept Sci; 2002 Jul; 8(7):314-26. PubMed ID: 12148781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three new epoxy-spirolactone derivatives: characterization in vivo and in vitro.
    de Gasparo M; Joss U; Ramjoué HP; Whitebread SE; Haenni H; Schenkel L; Kraehenbuehl C; Biollaz M; Grob J; Schmidlin J
    J Pharmacol Exp Ther; 1987 Feb; 240(2):650-6. PubMed ID: 2949071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The world of beta- and gamma-peptides comprised of homologated proteinogenic amino acids and other components.
    Seebach D; Beck AK; Bierbaum DJ
    Chem Biodivers; 2004 Aug; 1(8):1111-239. PubMed ID: 17191902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone antagonists. 2. New 7 alpha-(acetylthio)-15,16-methylene spirolactones.
    Nickisch K; Bittler D; Laurent H; Losert W; Casals-Stenzel J; Nishino Y; Schillinger E; Wiechert R
    J Med Chem; 1987 Aug; 30(8):1403-9. PubMed ID: 3612688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ring size or an additional heteroatom on the potency and selectivity of bicyclic benzylamine-type inhibitors of phenylethanolamine N-methyltransferase.
    Grunewald GL; Dahanukar VH; Ching P; Criscione KR
    J Med Chem; 1996 Aug; 39(18):3539-46. PubMed ID: 8784452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative dose-effect studies with four C-17-spirosteroidal mineralocorticoid synthesis inhibitors.
    Weindel K; Lewicka S; Vecsei P
    J Steroid Biochem; 1989; 34(1-6):455-9. PubMed ID: 2626039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldosterone antagonists. 1. Synthesis and activities of 6 beta,7 beta:15 beta,16 beta-dimethylene steroidal spirolactones.
    Nickisch K; Bittler D; Casals-Stenzel J; Laurent H; Nickolson R; Nishino Y; Petzoldt K; Wiechert R
    J Med Chem; 1985 May; 28(5):546-50. PubMed ID: 3989815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.